WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013059299) ANTIBODIES FOR INTERFERON SUBTYPES AND INTERFERON/INTERFERON RECEPTOR TERNARY COMPLEX AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/059299    International Application No.:    PCT/US2012/060589
Publication Date: 25.04.2013 International Filing Date: 17.10.2012
IPC:
C07K 16/28 (2006.01), C07K 16/24 (2006.01), C07K 16/18 (2006.01), A61K 39/395 (2006.01), A61P 31/12 (2006.01)
Applicants: THE UAB RESEARCH FOUNDATION [US/US]; AB770 1530 3rd Avenue South Birmingham, AL 35294-0107 (US).
THE UNIVERSITY OF TORONTO [CA/CA]; Mars Centre Heritage Building Suite 320 101 College Street Toronto, ON M5G 1L7 (CA)
Inventors: WALTER, Mark; (US).
SIDHU, Sachdev; (CA).
MIERSCH, Shane; (CA)
Agent: PRATT, John; Kilpatrick Townsend & Stockton LLP 1100 Peachtree Street Suite 2800 Atlanta, GA 30309-4530 (US)
Priority Data:
61/547,938 17.10.2011 US
Title (EN) ANTIBODIES FOR INTERFERON SUBTYPES AND INTERFERON/INTERFERON RECEPTOR TERNARY COMPLEX AND USES THEREOF
(FR) ANTICORPS DIRIGÉS CONTRE DIVERS SOUS-TYPES D'INTERFÉRON, COMPLEXE TERNAIRE INTERFÉRON/RÉCEPTEUR D'INTERFÉRON ET UTILISATIONS ASSOCIÉES
Abstract: front page image
(EN)Provided herein are antibodies or fragments thereof that specifically bind an interferon-interferon receptor ternary complex. Also provided herein are antibodies or fragments thereof that specifically bind one or two type I interferons. Also provided herein are methods of treating or preventing an autoimmune disease, viral infection, or cancer in a subject comprising administering an effective amount of any of the antibodies described herein to the subject.
(FR)La présente invention concerne des anticorps ou des fragments d'anticorps qui se lient spécifiquement à un complexe ternaire interféron-récepteur d'interféron. L'invention concerne également des anticorps ou des fragments d'anticorps qui se lient spécifiquement à un ou deux interférons de type I. L'invention concerne par ailleurs des méthodes de traitement ou de prévention d'une maladie auto-immune, d'une infection virale ou d'un cancer chez un sujet, lesdites méthodes comprenant l'administration audit sujet d'une quantité efficace de l'un quelconque des anticorps décrits ici.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)